scholarly article | Q13442814 |
P356 | DOI | 10.1038/HR.2014.32 |
P698 | PubMed publication ID | 24599014 |
P50 | author | Per Wändell | Q41146304 |
Axel C Carlsson | Q41718513 | ||
Jan Sundquist | Q60499958 | ||
P2093 | author name string | Kristina Sundquist | |
Sven-Erik Johansson | |||
P2860 | cites work | Treatment of hypertension: a failing report card | Q83032130 |
The role of 'confounding by indication' in assessing the effect of quality of care on disease outcomes in general practice: results of a case-control study | Q24800184 | ||
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE> | Q28204197 | ||
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins | Q29547856 | ||
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) | Q29618529 | ||
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials | Q34276433 | ||
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation | Q35003773 | ||
Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk | Q35539305 | ||
Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes. | Q36131480 | ||
Confounding and indication for treatment in evaluation of drug treatment for hypertension | Q36246956 | ||
Lipid-altering therapy and atrial fibrillation | Q37194309 | ||
Cholesterol and cardiac arrhythmias. | Q37770110 | ||
Country of birth, socioeconomic factors, and risk factor control in patients with type 2 diabetes: a Swedish study from 25 primary health-care centres | Q39784448 | ||
Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial | Q42684584 | ||
Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort | Q42850914 | ||
Physicians' gender is associated with risk factor control in patients on antihypertensive and lipid lowering treatment | Q43072104 | ||
Total mortality among levothyroxine-treated women with atrial fibrillation in Swedish primary health care | Q43970025 | ||
Requirements for utilizing health care-based data sources for research | Q45732219 | ||
Survival after stroke--the impact of CHADS2 score and atrial fibrillation. | Q45793807 | ||
Effect of cardiovascular drug classes on all-cause mortality among atrial fibrillation patients treated in primary care in Sweden: a cohort study | Q45813085 | ||
Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study | Q46551755 | ||
Coronary heart disease risks in first- and second-generation immigrants in Sweden: a follow-up study | Q47582597 | ||
Differences and time trends in drug treatment of atrial fibrillation in men and women and doctors' adherence to warfarin therapy recommendations: a Swedish study of prescribed drugs in primary care in 2002 and 2007. | Q47642306 | ||
Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. | Q48342135 | ||
Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study). | Q53252730 | ||
Factors associated with uncontrolled hypertension and cardiovascular risk in hypertensive 60-year-old men and women--a population-based study. | Q54187702 | ||
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committ | Q56626176 | ||
Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure - A population study | Q58666697 | ||
Longitudinal Study on Hypertension Control in Primary Care: The Insubria Study | Q59528623 | ||
Blood pressure control in Italy: results of recent surveys on hypertension | Q61456573 | ||
Inadequate Management of Blood Pressure in a Hypertensive Population | Q61822162 | ||
Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications | Q72566134 | ||
Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders | Q73712331 | ||
Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials | Q81897757 | ||
Atrial fibrillation in congestive heart failure | Q82242330 | ||
Treatment of atrial fibrillation | Q82854921 | ||
P433 | issue | 6 | |
P921 | main subject | Sweden | Q34 |
Atrial Fibrillation | Q815819 | ||
P304 | page(s) | 553-559 | |
P577 | publication date | 2014-03-06 | |
P1433 | published in | Hypertension Research | Q15762136 |
P1476 | title | Effects of prescribed antihypertensives and other cardiovascular drugs on mortality in patients with atrial fibrillation and hypertension: a cohort study from Sweden | |
P478 | volume | 37 |
Q56974145 | Cardiovascular drugs and mortality in hypertensive patients with atrial fibrillation: evidence of efficacy for a global approach |
Q42676657 | Effectiveness and safety of beta blockers in the management of hypertension in older adults: a systematic review to help reduce inappropriate prescribing |
Q51405999 | How to evaluate BP measurements using the oscillometric method in atrial fibrillation: the value of pulse rate variation. |
Q47418143 | Mortality in patients with atrial fibrillation and common co-morbidities - a cohort study in primary care |
Q35639707 | Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care |
Q36371930 | Neighbourhood socio-economic status and all-cause mortality in adults with atrial fibrillation: A cohort study of patients treated in primary care in Sweden |
Q47555897 | The association between relevant co-morbidities and prevalent as well as incident heart failure in patients with atrial fibrillation |
Q40051774 | The persisting gender gap in hypertension management and control in Germany: 1998 and 2008-2011. |
Q35647794 | Use of Loop Diuretics is Associated with Increased Mortality in Patients with Suspected Coronary Artery Disease, but without Systolic Heart Failure or Renal Impairment: An Observational Study Using Propensity Score Matching |
Search more.